IPHA
Price
$2.03
Change
-$0.00 (-0.00%)
Updated
Jul 25, 02:47 PM (EDT)
Capitalization
183.92M
54 days until earnings call
MDGL
Price
$298.60
Change
-$0.57 (-0.19%)
Updated
Jul 25, 04:59 PM (EDT)
Capitalization
6.64B
12 days until earnings call
Interact to see
Advertisement

IPHA vs MDGL

Header iconIPHA vs MDGL Comparison
Open Charts IPHA vs MDGLBanner chart's image
Innate Pharma SA
Price$2.03
Change-$0.00 (-0.00%)
Volume$200
Capitalization183.92M
Madrigal Pharmaceuticals
Price$298.60
Change-$0.57 (-0.19%)
Volume$3.61K
Capitalization6.64B
IPHA vs MDGL Comparison Chart in %
Loading...
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHA vs. MDGL commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHA is a Buy and MDGL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (IPHA: $2.03 vs. MDGL: $299.17)
Brand notoriety: IPHA and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHA: 89% vs. MDGL: 113%
Market capitalization -- IPHA: $183.92M vs. MDGL: $6.64B
IPHA [@Biotechnology] is valued at $183.92M. MDGL’s [@Biotechnology] market capitalization is $6.64B. The market cap for tickers in the [@Biotechnology] industry ranges from $309.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHA’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 0 green FA rating(s).

  • IPHA’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 0 green, 5 red.
According to our system of comparison, MDGL is a better buy in the long-term than IPHA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHA’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 5 bullish TA indicator(s).

  • IPHA’s TA Score: 5 bullish, 4 bearish.
  • MDGL’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, IPHA is a better buy in the short-term than MDGL.

Price Growth

IPHA (@Biotechnology) experienced а +14.92% price change this week, while MDGL (@Biotechnology) price change was -14.21% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.76%. For the same industry, the average monthly price growth was +19.76%, and the average quarterly price growth was +29.65%.

Reported Earning Dates

IPHA is expected to report earnings on Sep 17, 2025.

MDGL is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+8.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.64B) has a higher market cap than IPHA($184M). IPHA YTD gains are higher at: 10.576 vs. MDGL (-3.046).
IPHAMDGLIPHA / MDGL
Capitalization184M6.64B3%
EBITDAN/A-376.15M-
Gain YTD10.576-3.046-347%
P/E RatioN/AN/A-
RevenueN/A317M-
Total CashN/A843M-
Total DebtN/A120M-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
66
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
43
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
56
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IPHAMDGL
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 12 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 2 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
IPHA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMPFX44.800.14
+0.31%
American Funds AMCAP F1
GCBLX35.72N/A
N/A
Green Century Balanced
GCMUX38.64N/A
N/A
Goldman Sachs Mid Cap Value R6
IRTCX27.72N/A
N/A
Invesco Dividend Income R
LCISX27.51N/A
N/A
ClearBridge Sustainability Leaders I

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-2.47%
KANT - MDGL
62%
Loosely correlated
N/A
ALXO - MDGL
56%
Loosely correlated
+6.68%
NAGE - MDGL
45%
Loosely correlated
-5.98%
IPHA - MDGL
44%
Loosely correlated
+2.80%
RNAC - MDGL
43%
Loosely correlated
+0.52%
More